Plagiarism/Ethics Statement

Plagiarism and Publication Ethics Statement

Annals of Stem Cell Research is committed to promoting the highest standards of publication ethics, scientific integrity, and responsible research practices. The journal provides a platform for the publication of high-quality research in stem cell biology, regenerative medicine, tissue engineering, cellular therapy, developmental biology, and related biomedical sciences. Authors, reviewers, editors, and editorial staff are expected to uphold ethical principles that ensure transparency, accountability, and the reliability of the published scientific record.

Authors must submit manuscripts that are original, scientifically rigorous, and not under consideration by another journal. All ideas, data, figures, tables, images, and previously published material must be appropriately acknowledged through accurate citation and referencing. The journal has a zero-tolerance policy toward plagiarism, self-plagiarism, duplicate publication, data fabrication, data falsification, inappropriate image manipulation, and any other form of research misconduct. Manuscripts found to violate these ethical standards may be rejected during the editorial process or, if already published, may be corrected, retracted, or subject to other appropriate editorial actions following a thorough investigation.

Research involving human participants, including studies using human stem cells or biological specimens, must comply with internationally recognized ethical principles and applicable institutional and national regulations. Where required, authors must obtain approval from an appropriate Institutional Review Board (IRB) or Ethics Committee before commencing the study and confirm that informed consent was obtained from participants or their legally authorized representatives. All research involving human biological materials should respect donor rights, privacy, confidentiality, and applicable legal and ethical requirements.

Studies involving animals must be conducted in accordance with recognized guidelines for the ethical care and use of laboratory animals. Authors should provide details of the relevant ethical approvals and describe the measures implemented to minimize pain, distress, and unnecessary animal use.

The journal requires complete disclosure of all sources of funding, financial support, and any actual or potential conflicts of interest that could influence the design, conduct, analysis, interpretation, or reporting of the research. Individual author contributions should be clearly described to promote accountability and transparency. Authors are encouraged to retain original research data and, where appropriate, make supporting datasets available to facilitate verification, reproducibility, and further scientific investigation.

Editors are responsible for ensuring a fair, impartial, confidential, and timely editorial process. Manuscripts are evaluated solely on the basis of scientific merit, originality, methodological quality, ethical compliance, and relevance to the journal's scope. Reviewers are expected to provide objective, constructive, and confidential assessments while declaring any conflicts of interest that may compromise their impartiality.

When ethical concerns arise before or after publication, the journal will investigate them promptly, fairly, and confidentially. If misconduct is confirmed, appropriate editorial actions—including corrections, expressions of concern, or article retractions—will be taken to preserve the integrity and credibility of the scientific literature.

Annals of Stem Cell Research is dedicated to fostering ethical scientific publishing and supporting innovative, high-quality research that advances stem cell science, regenerative medicine, and translational therapies for the benefit of patients and the global scientific community.